Table 1 Demographics and clinical characteristics of children
From: Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study
N (%) unless otherwise specified | All N =7 9 eyes | JIA-U N =3 4 eyes | I-CAU N =4 5 eyes |
|---|---|---|---|
Female | 6 (86) | 3 (100) | 3 (75) |
Race | |||
 Caucasian | 3 (43) | 2 (67) | 1 (25) |
 African-American | 4 (57) | 1 (33) | 3 (75) |
 Non-Hispanic | 7 (100) | 3 (100) | 4 (100) |
Disease characteristics | |||
 Median age at uveitis diagnosis, years, SD | 6, 9 | 6, 5.6 | 8.8, 5.3 |
 Median age at tear collection, years, SD | 15, 1.8 | – | – |
 Bilateral disease | 6 (86) | 2 (67) | 4 (100) |
 Ocular complicationsa | 7 (100) | 3 (100) | 4 (100) |
 ANA-positive | 4 (57) | 3 (100) | 1 (25) |
Medications | |||
 Topical glucocorticoids | 4 (57) | 1 (33) | 3 (75) |
 Topical glaucoma medications | 1 (14) | 0 (0) | 1 (25) |
 Methotrexate | 4 (57) | 1 (33) | 3 (75) |
 Mycophenolate mofetil | 1 (14) | 0 (0) | 1 (25) |
 Infliximab | 1 (14) | 1 (33) | 0 (0) |
 Adalimumab | 2 (28) | 1 (33) | 1 (25) |